US Department of Defense Recommends Soldiers Carry WoundStat™
for Life-Threatening Bleeding
US Military Finds WoundStat the Most Effective Hemostatic Agent
Available
BETHESDA, Md. (Business Wire EON/PRWEB ) June 3, 2008 --
TraumaCure Inc. announced today that the DOD Joint Committee on Tactical
Combat Casualty Care (CoTCCC) has recommended that U.S. soldiers from
all services carry the company’s hemostatic
agent, WoundStat™.
The CoTCCC based its recommendations upon the results of extensive
studies conducted by both the Army’s Institute
for Surgical Research (ISR) and the Naval Medical Research Center
(NMRC). In those studies, no other product was as effective across the
board in terms of survival, post treatment blood loss, and duration of
hemostasis.
This is the first time ever that all branches of the military have come
together and jointly recommended the same product for the most severe
injuries involving high-pressure bleeding.
“Severe bleeding is the number one cause of
death for soldiers injured in battle. The ISR study clearly shows
WoundStat works consistently to stop serious bleeding quickly. In light
of these study results, WoundStat will be a critical product in the
field available to all soldiers in harm’s way,
where and when it is needed most,” said Ron
Blanck, retired US Army Surgeon General. “Approximately
80% of injuries in the current conflict are from improvised explosive
devices (IEDs), which result in the severe and irregular wounds that
WoundStat is specifically designed to treat. In those situations,
WoundStat works in seconds, not minutes.”
Four different studies—including the one
conducted by the Army’s ISR, along with
others conducted at Virginia Commonwealth University, the Air Force, and
NAMSA—have now proven that WoundStat is the
most effective hemostat available for high pressure arterial wounds. In
each of these studies, WoundStat was the only product that resulted in
100% survival. The novel wound treatment works through standing blood
and has the added advantage that, should re-bleeding occur, a wound can
be re-packed with the WoundStat already present—a
real advantage in combat conditions.
“The Joint Committee on TCCC recognized
WoundStat’s overall advantage in both
effectiveness and safety. It is now clearly proven that, with its
consistent reliability and efficacy, combined with its speed of use,
WoundStat offers the highest level of operational field capability for
our warfighters,” noted Devinder S. Bawa, CEO
of TraumaCure.
TraumaCure has enough WoundStat in stock to equip every soldier
currently deployed in the Middle East theater. The cost of WoundStat is
about one-third that of the product the Army has been using for the past
several years. WoundStat is also available for domestic use by emergency
responders and others who need to be prepared for treating traumatic
injuries.
About TraumaCure
TraumaCure, based in Bethesda, Maryland, supplies the most effective,
reliable treatments for life-threatening bleeding wounds. TraumaCure’s
hemostatic products help stabilize a wounded individual prior to
receiving advanced medical treatment. The company’s
products are made in the U.S. and are proven to save lives and improve
outcomes following traumatic injury. TraumaCure is committed to
providing the most trustworthy and innovative hemostasis treatments for
the military, emergency responders, and civilians.
Post Comment:
Trackback URL: http://www.prweb.com/pingpr.php/SW5zZS1JbnNlLVNxdWEtUGlnZy1Qcm9mLVplcm8=
Bookmark -
Del.icio.us |
Furl It |
Technorati |
Ask |
MyWeb |
Propeller |
Live Bookmarks |
Newsvine |
TailRank |
Reddit |
Slashdot |
Digg |
Stumbleupon |
Google Bookmarks |
Sphere |
Blink It |
Spurl
|
Share The News
Submit this press release easily to any of these major bookmarking and social media sites.